Investing

ImmunityBio : IBRX

IBRX

Stock Data

$9.44

$0.24 (2.61%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

ImmunityBio Inc is a trailblazer in the biotechnology sector, focusing on innovative therapies and vaccines to empower the immune system against cancers and infectious diseases. With a rich pipeline that includes immunotherapy, cell therapy, and cutting-edge vaccine technologies, the company is actively advancing treatments for a variety of cancers and pathogens, including COVID-19 and HIV. Based in San Diego, California, ImmunityBio's collaborative efforts extend to notable institutions and companies, aiming to revolutionize healthcare with its groundbreaking research.